Butterfly Network (BFLY) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- —
- Estimate
- -$0.03
- Surprise
- —
- Score today
- 5.9/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- Butterfly Network Sees Q4 Sales $31.000M-$34.000M vs $33.241M Est — benzinga, 2026-10-29
Where TrendMatrix's rating stands now
TrendMatrix currently rates BFLY Hold at 5.9/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Supplier: TSMC
- Concentration risk — Supplier: Benchmark
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $7.81
- Price target
- $9.72
- Stop
- $7.26
- Upside to target
- +24.5%
- Reward-to-risk
- 1.6:1
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
BFLY at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $2.08B
- P/E (fwd)
- -115.7
- 52-week range
- $1.90–$10.21
- Off 52-week high
- 23.5%
- RSI (14)
- 48
- Volume vs avg
- 1.13×
- Score today
- 5.9/10